# Lyrica

NDC: 0071-1018
Generic name: PREGABALIN
Labeler / Manufacturer: Parke-Davis Div of Pfizer Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20041230
Marketing ended: 20261231
FDA application: NDA021446

## Active ingredients

- PREGABALIN: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0071-1018"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0071-1018
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=60185c88-ecfd-46f9-adb9-b97c6b00a553